Tag: tyrosine kinase inhibitors market trends

Global tyrosine kinase inhibitors market size is expected to reach $81.41 Bn by 2028 at a rate of 8.5%, segmented as by type, bcr-abl tyrosine kinase inhibitor, epidermal growth factor receptor (egfr) tyrosine kinase inhibitors
Healthcare

Tyrosine Kinase Inhibitors Market Size, Share, Revenue, Trends And Drivers For 2024-2033 | Pfizer Inc., Johnson And Johnson Private Limited., F. Hoffmann-La Roche AG, AbbVie Inc., Bayer AG

- by Top PR News

Overview and Scope Tyrosine kinase inhibitors (TKI) refer to a class of pharmaceuticals that block several ways protein kinases signal the transduction pathway’s function. It is used in targeted therapy …

Tyrosine Kinase Inhibitors Market Size, Share, Revenue, Trends And Drivers For 2024-2033 | Pfizer Inc., Johnson And Johnson Private Limited., F. Hoffmann-La Roche AG, AbbVie Inc., Bayer AG Read More